角膜缘松解切开在ICL术中的应用

注册号:

Registration number:

ChiCTR-ONR-17011147 

最近更新日期:

Date of Last Refreshed on:

2017-04-14 13:31:20 

注册时间:

Date of Registration:

2017-04-14 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

角膜缘松解切开在ICL术中的应用

Public title:

Effect of Limbal Relaxing Incisions during implantable collamer lens surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

角膜缘松解切开在ICL术中的应用

Scientific title:

Effect of Limbal Relaxing Incisions during implantable collamer lens surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李臻 

研究负责人:

李臻 

Applicant:

Zhen Li 

Study leader:

Zhen Li 

申请注册联系人电话:

Applicant telephone:

+86 18081316852

研究负责人电话:

Study leader's
telephone:

+86 18081316852

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lizhen81131@163.com

研究负责人电子邮件:

Study leader's E-mail:

lizhen81131@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省乐山市人民医院眼科

研究负责人通讯地址:

四川省乐山市人民医院眼科

Applicant address:

635 Wanghaoer Steet, Leshan, Sichuan, China

Study leader's address:

635 Wanghaoer Steet, Leshan, Sichuan, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川省乐山市人民医院

Applicant's institution:

Leshan People's Hospital

研究负责人所在单位:

四川省乐山市人民医院

Affiliation of the Leader:

Leshan People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2015-40

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

乐山市人民医院伦理委员会

Name of the ethic committee:

The ethics committee of Leshan pepole’s hospital

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

乐山市人民医院

Primary sponsor:

Leshan people's hopital

研究实施负责(组长)单位地址:

乐山市市中区王浩儿街635号

Primary sponsor's address:

635 Wanghaoer Steet, Leshan, Sichuan, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

乐山市

Country:

China

Province:

Sichuan

City:

单位(医院):

乐山市人民医院

具体地址:

乐山市市中区王浩儿街635号

Institution
hospital:

Leshan people's hospital

Address:

635 Wanghaoer Steet,Leshan,Sichuan, 614000

经费或物资来源:

四川省卫生厅

Source(s) of funding:

the science and technology foundation of Sichuan Provincial Health and Family Planning Commission(NO.150065).

研究疾病:

近视散光  

Target disease:

astigmatism and myopia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

观察LRI技术在ICL术中的安有效性和有效性  

Objectives of Study:

To study the effect of limbal relaxing inci?sions during implantable collamer lens(ICL) surgery

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

眼部活动性疾病,角膜不透明,不规则角膜散光,胬肉,眼表手术史

Exclusion criteria:

Exclusion criteria included irregular corneal astigmatism, keratoconus or keratoconus suspect, current uveitis, marked corneal scarring , pannus, and pterygium in preoperative topography,unclear cornea, with no history of previous ocular surgery.

研究实施时间:

Study execute time:

From 2015-01-01 00:00:00 To 2017-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2015-01-01 00:00:00 To 2017-12-31 00:00:00

干预措施:

Interventions:

组别:

3

样本量:

180

Group:

3 groups

Sample size:

干预措施:

角膜缘松解切口

干预措施代码:

Intervention:

Limbal Relaxing Incisions

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

乐山市 

Country:

China

Province:

Sichuan

City:

Leshan

单位(医院):

乐山市人民医院 

单位级别:

三甲医院 

Institution
hospital:

Leshan people's hospital

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

散光

指标类型:

主要指标

Outcome:

astigmatism

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

角膜地形图

组织:

不需要人体组织

Sample Name:

potographic

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

电脑随机产生

Randomization Procedure (please state who generates the random number sequence and by what method):

computer operation

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过ResMan提供原始数据查询

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

IPD will be public accessable via ResMan

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Excel和纸质资料

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Excel

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2017-04-14 13:30:22